Speaker: Maurice Treacy, Co-founder and Commercial Officer & Company Director at Open Orphan
Open Orphan plc (ORPH) is a European-focused, rare and orphan drug consulting services platform. The Company intends to roll up a number of orphan drug services business and has two data driven digital platforms, a Genomic Health Data Platform, which is establishing a rare disease database which will also facilitate clinical trial recruitment and a Virtual Rep platform enabling pharmaceutical companies to engage key opinion leaders and physicians. The company also offers both early development services and clinical development services. The Company is targeting rapid growth in one of the fastest growing sectors in the global pharmaceutical industry targeting under-supplied treatment for life threatening or very serious diseases and rare disorders.